BDBM675527 US11987556, Compound 2

SMILES CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(=O)COC(=O)C(C)(CO[N+]([O-])=O)CO[N+]([O-])=O)c2C1=O

InChI Key InChIKey=KLNHICGEAYBYPG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 675527   

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675527(US11987556, Compound 2)
Affinity DataIC50: 308nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4C(Human)
Biofront Therapeutics (Beijing) Co.

US Patent
LigandPNGBDBM675527(US11987556, Compound 2)
Affinity DataIC50: 2.26E+3nMAssay Description:The inhibition of PDE4 (e.g., PDE4A, PDE4C) activity by the compounds (e.g., compound-1, compound-2, compound-3, compound-4, compound-5, and compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent